The development of pancreatic cancer is dependent on numerous oncogenic modifications. Kras would be the most frequently mutated gene (G12D allele) in pancreatic most cancers and it is present in 95% of pancreatic cancers26. Even though genetically engineered mouse (GEM) versions have convincingly demonstrated that constitutive activation of Kras by https://taylorm663nsw6.oblogation.com/profile